Presentations & Events
Spotlight on Recent Biodesix Presentations
September 2025 | The APAPP Podcast
Know Your Nodules: Personalize, Prioritize, Prevent
IP Chair Rebecca Priebe NSM, ACNP-BC, FCCP (Henry Ford Health) and Tammy Welch PA (Frederick Regional Health System) discuss the critical aspects of lung nodule management and lung cancer screening. They explore the importance of early detection, establishing a lung nodule surveillance program, and the integration of Nodify Lung® testing for risk stratification. The conversation highlights the challenges faced in patient management, the significance of effective communication with primary care providers, and the impact of lung cancer screening programs on patient outcomes.
Know Your Nodules: Personalize, Prioritize, Prevent
IP Chair Rebecca Priebe NSM, ACNP-BC, FCCP (Henry Ford Health) and Tammy Welch PA (Frederick Regional Health System) discuss the critical aspects of lung nodule management and lung cancer screening. They explore the importance of early detection, establishing a lung nodule surveillance program, and the integration of Nodify Lung® testing for risk stratification. The conversation highlights the challenges faced in patient management, the significance of effective communication with primary care providers, and the impact of lung cancer screening programs on patient outcomes.
May 2025 | ISPOR 2025 + ATS 2025
Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS.
“Time to Diagnosis of Lung Cancer from Identification of a Pulmonary Nodule in the United States” by Kimberly Le, Biodesix Director of Health Economics and Outcomes Research at ISPOR 2025.
“Utilization of Proteomic Testing in Pulmonary Nodule Risk Stratification at a Safety-Net Hospital: An Observational Study” by Sonu Sahni, MD, Director of Lung Cancer Screening at Wyckoff Heights Medical Center in New York at the ATS 2025 Conference
Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS.
“Time to Diagnosis of Lung Cancer from Identification of a Pulmonary Nodule in the United States” by Kimberly Le, Biodesix Director of Health Economics and Outcomes Research at ISPOR 2025.
“Utilization of Proteomic Testing in Pulmonary Nodule Risk Stratification at a Safety-Net Hospital: An Observational Study” by Sonu Sahni, MD, Director of Lung Cancer Screening at Wyckoff Heights Medical Center in New York at the ATS 2025 Conference
May 2025 | ASCO 2025
Host immune classifier to predict survival with chemoimmunotherapy in PD-L1 ≥50% metastatic NSCLC
Presented by:
Dr. Vamsidhar Velcheti, MD, Director of Thoracic Oncology at NYU Langone’s Perlmutter Cancer Center
Upcoming Biodesix Presentations and Events
September 13 – 16, 2025 | Orlando, FL | College of American Pathologists (CAP) 2025 Annual Meeting
- September 15th at 12 PM ET| "Introduction of new IVD solution for rapid NGS profiling in Oncology Sponsored by Thermo Fisher Scientific"
Speakers: Gary Pestano, Ph.D., Chief Development Officer, Biodesix; Mahmoud Elsayad, MD, FCAP, University of Texas Health; and Alison Roos, Thermo Fisher Scientific
- September 17th at 9:30 AM ET| Presentation on "Rapid Turnaround Liquid Biopsy testing in the Evaluation of RAS Mutational Status During Treatment"
Speaker: Michael Sweeney, Director - Alliance Management & Business Development, Biodesix
- September 24th at 11:20 AM ET| Presentation on "Driving Drug Development with Integrated Multi-Omic Insights: Unlocking Precision Medicine with Biodesix’ Comprehensive Service Offerings"
Speaker: Colin McDowell, Ph.D., Senior Manager - Business Development, Biodesix
- October 9, 2025 | Biodesix HQ, Louisville, CO| "Know Your Nodules" event hosted by Association of Pulmonary Advanced Practice Providers
- October 9 – 11, 2025 | Denver, CO | GO2 for Lung Cancer 2025 Centers of Excellence Summit
- October 12, 2025 | Red Rocks Amphitheater, Morrison, CO | American Lung Association in Colorado Run the Rocks 2025
- October 19th | Team Biodesix Lung Cancer Research Foundation Free to Breathe Walk at CHEST Chicago
- October 21st at 2:00 PM CT| Learning Theater Presentation on Driving to a New Standard of Care in Lung Nodule Management: Preliminary Results From the Nodify Lung Real-World CLARIFY Study
Speaker: Michael Kammer, Ph.D., Head of Radiomics, Biodesix
- November 10th at 9:30 AM BST| Poster Session 1 | "Pulmonary Nodule (PN)-related and Lung Cancer-related Workup Costs within the Two-Year Period after Diagnosis of a PN in the United States"
Presented by Kimberly Le, Director - Health Economics Outcomes Research, Biodesix
- November 12th at 4:00 PM ET| Biodesix Corporate Workshop
View Past Biodesix Presentations and Events
Technology Networks: Future of Molecular Diagnostics Webinar
CAP TODAY / Thermo Fisher Scientific Webinar: Introduction of new FDA approved rapid NGS solution for Companion Diagnostics & tumor profiling in oncology
Speaker Emma Longshore, Biodesix Bioinformatician
CAP TODAY / Thermo Fisher Scientific Webinar: Introduction of new FDA approved rapid NGS solution for Companion Diagnostics & tumor profiling in oncology
Speakers: Gary Pestano, Ph.D., Chief Development Officer, Biodesix; David Chi, PhD, Thermo Fisher Scientific; and Bence Sipos, MD
Bio-Rad Laboratories ddPCR World 2025
73rd Conference on Mass Spectrometry and Allied Topics
Session by Leisa Jackson, Biodesix Staff Scientist, on Development of a Highly Sensitive and Specific Droplet Digital PCR Assay for Multiplexed Detection and Longitudinal Monitoring of ESR1 Variants in Plasma: A QX600 Case Study
73rd Conference on Mass Spectrometry and Allied Topics
Poster presentation by Amanda Weaver, Biodesix Staff Scientist, on "Clinical Results of a mCRPC Cohort with Automated MALDI-TOF Sample Preparation Utilizing the Felix Liquid Handler and Active Drier"
Poster presentation by Sarah Phillips, Biodesix Senior Scientist, on "Optimizing Testing Capacity for a Clinical Proteomics MRM Assay: Expanding HPLC and Plate-Based Depletion Methods"
ISPOR 2025
Life Sciences - In Focus: Laboratory Developed Tests: What Now, Where Next?
ATS 2025 International Conference
Poster presentation by Kimberly Le, PharmD, Biodesix Director of HEOR, on Time to Diagnosis of Lung Cancer From Identification of a Pulmonary Nodule in the United States.
Life Sciences - In Focus: Laboratory Developed Tests: What Now, Where Next?
Panel Discussion with Tristin Wolff Cope, Director of Regulatory Compliance. Sponsored by Vistatec and RAPS Colorado Chapter.
ATS 2025 International Conference
American Association for Cancer Research Annual Meeting 2025
Spotlight theater presentation featuring Gary Pestano, Ph.D., Chief Development Officer, Biodesix on Developing Multi-Modal MRD and ctDNA Tests for Use in Clinical Research: Droplet Digital PCR-Driven Mutations and Methylation Quantification, CTCs and Proteomics. – Sponsored by Bio-Rad Laboratories.
9th Annual Liquid Biopsy for Precision Oncology Summit
Panel Discussion moderated by Matthew Pink Vice President of Business Development, Biodesix: Harnessing MRD & ctDNA to Inform Clinical Trial Decision Making & Improve Dosage Regimens
Presentation by Gary Pestano, Ph.D., Chief Development Officer, Biodesix: Empowering Precision Oncology & MRD Monitoring through ctDNA & CTC Analysis – Sponsored by Bio-Rad Laboratories.
Friends of Cancer Research Advancing the Future of Diagnostics and Regulatory Innovations White Paper co-authored Gary Pestano, Ph.D., Chief Development Officer, Biodesix and Brianna Phillips, Vice President of Quality and Regulatory Affairs, Biodesix: Innovative Validation and Regulatory Processes for Companion Diagnostic Tests for Rare Biomarkers or Indications
Friends of Cancer Research Advancing the Future of Diagnostics and Regulatory Innovations White Paper co-authored Gary Pestano, Ph.D., Chief Development Officer, Biodesix and Brianna Phillips, Vice President of Quality and Regulatory Affairs, Biodesix: Innovative Validation and Regulatory Processes for Companion Diagnostic Tests for Rare Biomarkers or Indications
AMP 2024 Annual Meeting & Expo
Presentation by Gary Pestano, Ph.D., Chief Development Officer, Biodesix: Droplet Digital PCR (ddPCR) in Precision Oncology and MRD: Perspectives from the Trenches
Poster Presentation by Leisa Jackson, Staff Scientist, Biodesix & Gary Pestano, Ph.D., Chief Development Officer, Biodesix: TT037 Development of a Clinical-Grade Droplet Digital PCR Workflow for Blood-Based Detection of Cancer Relevant miRNAs
Droplet Digital and ddPCR are trademarks of Bio-Rad Laboratories, Inc.
ISPOR Europe 2024 Poster presentations by Kimberly Le, PharmD, Director of Health Economics Outcomes Research, Biodesix:
AACR Special Conference in Cancer Research: Liquid Biopsy: From Discovery to Clinical Implementation Poster Presentation by Colin McDowell, Ph.D. Senior Manager of Business Development, Biodesix: A032 Performance evaluation of a new protein stabilizing blood collection tube with a novel whole blood separation device for clinical plasma proteomics
ISPOR Europe 2024 Poster presentations by Kimberly Le, PharmD, Director of Health Economics Outcomes Research, Biodesix:
- EPH31: Incidence of Pulmonary Nodules (PNs) During the Coronavirus Disease (COVID-19) Pandemic in the United States (US)
- EPH93: Prevalence of Pulmonary Nodules (PNs) in 2020 During the Coronavirus Disease (COVID-19) Pandemic in the United States (US)
- EE438: Economic Impact Model to Estimate the Value of Blood-Based Biomarkers in the Risk Assessment of Pulmonary Nodules (PNS) From a Health System Perspective
- EPH208: Prevalence of Pulmonary Nodules (PNs) in 2019 in the United States (US)
- EHP209: Incidence of Pulmonary Nodules (PNs) in 2019 in the United States (US)
- CO183: Clinical Impact Model for Blood-Based Biomarkers in the Risk Assessment of Pulmonary Nodules (PNs) From a Health System Perspective
AACR Special Conference in Cancer Research: Liquid Biopsy: From Discovery to Clinical Implementation Poster Presentation by Colin McDowell, Ph.D. Senior Manager of Business Development, Biodesix: A032 Performance evaluation of a new protein stabilizing blood collection tube with a novel whole blood separation device for clinical plasma proteomics
CHEST 2024 Annual Meeting
CHEST Learning Theater Presentation by Sonali Sethi, MD, FCCP, Pulmonary Medicine, Cleveland Clinic and D. Kyle Hogarth, MD, FCCP, Professor of Medicine, University of Chicago: “Patient impact & case studies - the real-world value of biomarkers in lung nodule management”
Go2 for Lung Cancer Centers of Excellence (COE) Summit
Droplet Digital PCR World 2024 Asia Presentation by Gary Pestano, Ph.D., Chief Development Officer, Biodesix: From Feasibility to Clinical Testing for Rare Variants in Oncology: 10 years of ddPCR Experiences
Droplet Digital PCR World 2024 Asia Presentation by Gary Pestano, Ph.D., Chief Development Officer, Biodesix: From Feasibility to Clinical Testing for Rare Variants in Oncology: 10 years of ddPCR Experiences